Pfizer Inc. et al v. Changzhou Pharmaceutical Factory

1:24-cv-00623 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Colm F. Connolly
Filed May 23, 2024
Case Flags ANDA and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
Lead Case 1:24-cv-00621
The docket is incomplete. Sign up for verified information.
Upcoming Events
5 Months
  • 9/5/2025
Joint Claim Construction Brief due by 9/5/2025.
Source
Add
6 Months
  • 9/26/2025
Amended Pleadings due by 9/26/2025.
Joinder of Parties due by 9/26/2025.
Source
Add
7 Months
  • 10/22/2025
A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly.
Source
Add
12 Months
  • 3/25/2026
Fact Discovery completed by 3/25/2026.
Source
Add
18 Months
  • 9/24/2026
Expert Discovery due by 9/24/2026.
Source
Add
22 Months
  • 1/15/2027
Proposed Pretrial Order due by 1/15/2027.
Source
Add
22 Months
  • 2/8/2027
A Final Pretrial Conference is set for 2/8/2027 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.
Source
Add
23 Months
  • 2/16/2027
A Bench Trial is set for 2/16/2027 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.
Source
Add
Show 4 More Events
Filing Date # Docket Text
3/14/2025Notice - Other
9/30/2024Case associated with lead case: Create association to 1:24-cv-00621-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 24-621-CFC ONLY. (nmf) (Entered: 09/30/2024)
9/30/2024SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all future filings shall be made in Lead Case No. 24-621-CFC ONLY. Joinder of Parties due by 9/26/2025. Amended Pleadings due by 9/26/2025. Fact Discovery completed by 3/25/2026. Expert Discovery due by 9/24/2026. Joint Claim Construction Brief due by 9/5/2025. A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/15/2027. A Final Pretrial Conference is set for 2/8/2027 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/16/2027 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 09/30/2024)
9/30/2024 PROPOSED ORDER --[Proposed] Scheduling Order-- by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals, Pfizer Ireland Pharmaceutials. (Attachments: # 1 Letter to Judge Connolly)(Dellinger, Megan) (Entered: 09/30/2024)
9/20/2024NOTICE of Appearance by Neal C. Belgam on behalf of Changzhou Pharmaceutical Factory (Belgam, Neal) (Entered: 09/20/2024)
8/12/2024Order Setting In-Person Scheduling Conference: A Scheduling Conference is set for 10/2/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 8/12/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 08/12/2024)
8/8/2024 Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding response to the Court's July 8, 2024 Order - re (20 in 1:24-cv-00621-CFC, 20 in 1:24-cv-00621-CFC, 12 in 1:24-cv-00625-CFC, 12 in 1:24-cv-00625-CFC, 13 in 1:24-cv-00626-CFC, 13 in 1:24-cv-00626-CFC, 12 in 1:24-cv-00623-CFC, 12 in 1:24-cv-00623-CFC, 13 in 1:24-cv-00627-CFC, 13 in 1:24-cv-00627-CFC, 12 in 1:24-cv-00624-CFC, 12 in 1:24-cv-00624-CFC, 13 in 1:24-cv-00622-CFC, 13 in 1:24-cv-00622-CFC) Order,, Set Deadlines,. (Dellinger, Megan) (Entered: 08/08/2024)
8/7/2024Pro Hac Vice Attorney H. Howard Wang for Changzhou Pharmaceutical Factory added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 08/07/2024)
8/7/2024NOTICE OF SERVICE of Defendant Changzhou Pharmaceutical Factory's confidential ANDA, pursuant to D. Del. LR 26.2 filed by Changzhou Pharmaceutical Factory.(Taylor, Daniel) (Entered: 08/07/2024)
8/7/2024SO ORDERED, re 15 MOTION for Pro Hac Vice Appearance of Attorney H. Howard Wang, filed by Changzhou Pharmaceutical Factory. Ordered by Judge Colm F. Connolly on 8/7/2024. (kmd) (Entered: 08/07/2024)
8/7/202416Pro Hac Vice Fee - Credit Card Payment received for H. Howard Wang. ( re 15 MOTION for Pro Hac Vice Appearance of Attorney H. Howard Wang )( Payment of $ 50, receipt number ADEDC-4470588).(Taylor, Daniel) (Entered: 08/07/2024)
8/7/2024MOTION for Pro Hac Vice Appearance of Attorney H. Howard Wang - filed by Changzhou Pharmaceutical Factory. (Taylor, Daniel) (Entered: 08/07/2024)
8/5/2024 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent SPH Changzhou Pharmaceutical Co., Ltd. for Changzhou Pharmaceutical Factory filed by Changzhou Pharmaceutical Factory. (Taylor, Daniel) (Entered: 08/05/2024)
8/5/2024 ANSWER to 1 Complaint, and Additional Defenses by Changzhou Pharmaceutical Factory.(Taylor, Daniel) (Entered: 08/05/2024)
7/8/2024ORDER: on or before August 9, 2024, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/ or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER Setting Deadlines: ( Notice of Compliance deadline set for 8/9/2024.) Signed by Judge Colm F. Connolly on 7/8/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 07/08/2024)
6/12/2024WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc., Bristol-Myers Squibb Company: For Changzhou Pharmaceutical Factory waiver sent on 6/4/2024, answer due 8/5/2024. (Dellinger, Megan) (Entered: 06/12/2024)
5/31/2024Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024)
5/31/2024Pro Hac Vice Attorney Dimitrios T. Drivas for Pfizer Inc.,and for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024)
5/31/2024Pro Hac Vice Attorney Joel L. Broussard for Pfizer Inc. and for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024)
5/30/2024SO ORDERED, re (8 in 1:24-cv-00626-CFC, 8 in 1:24-cv-00627-CFC, 10 in 1:24-cv-00625-CFC, 11 in 1:24-cv-00622-CFC, 9 in 1:24-cv-00623-CFC, 10 in 1:24-cv-00624-CFC, 9 in 1:24-cv-00621-CFC) MOTION for Pro Hac Vice Appearance of Attorneys Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceuticals. Ordered by Judge Colm F. Connolly on 5/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(kmd) (Entered: 05/30/2024)
5/30/202410Pro Hac Vice Fee - Credit Card Payment received for Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard. ( re 9 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard )( Payment of $ 150, receipt number ADEDC-4419015).(Dellinger, Megan) (Entered: 05/30/2024)
5/30/2024MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard - filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials. (Dellinger, Megan) (Entered: 05/30/2024)
5/29/2024STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 05/29/2024)
5/29/2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00621-CFC through 1:24-cv-00627-CFC (rjb) (Entered: 05/29/2024)
5/23/2024Summons Issued as to Changzhou Pharmaceutical Factory on 5/23/2024. (mpb) (Entered: 05/24/2024)
5/23/2024 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company. (mpb) (Entered: 05/24/2024)
5/23/2024 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Pfizer Ireland Pharmaceuticals filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals. (mpb) (Entered: 05/24/2024)
5/23/2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,314,117 B2; 8,759,372 B2; 11,083,724 B2. (mpb) (Entered: 05/24/2024)
5/23/2024 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/16/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/27/2027. (mpb) (Entered: 05/24/2024)
5/23/2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 05/24/2024)
5/23/2024COMPLAINT filed against Changzhou Pharmaceutical Factory ( Filing fee $ 405, receipt number ADEDC-4414649.) - filed by Pfizer Ireland Pharmaceuticals, Pfizer Inc., Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(mpb) (Entered: 05/24/2024)